Mirtazapine anxiety disorder clinical observation of senile.doc

 PAGE \* MERGEFORMAT 5 Mirtazapine anxiety disorder clinical observation of senile [Abstract] Objective: To analyze the treatment of senile mirtazapine anxiety efficacy and safety. Methods: We randomly selected 30 patients with senile anxiety using the Hamilton anxiety rating scale of clinical efficacy in the treatment of 2,4 before and after treatment , 6,8 week 1 of the assessment. Results: mirtazapine for 8 weeks, 9 cases were cured, 14 cases of significant progress, progress in 3 cases, 4 cases, markedly effective rate was 86.7%. Conclusion: Mirtazapine for old age anxiety disorder patients have good therapeutic effect, rapid onset of adverse reactions. [Keywords:] anxiety disorder, mirtazapine Mirtazapine is a new type of antidepressant, and its relatively unique mechanism of action, the Department of norepinephrine (NE energy and specific serotonin (5-TH can be antidepressants, not only has therapeutic effects on depression and anxiety anxiolytic effects of better disease [1]. In this study of mirtazapine in elderly patients with anxiety disorders and adverse effects, are as follows. 1 Subjects and methods 1.1 The object of our hospital in January 2007 to July 2007 the clinic patients, agegt; = 65 years of age. Are in line with the Chinese Classification and Diagnostic Criteria of Mental Disorders 3rd Edition diagnostic criteria for anxiety disorders, Hamilton Anxiety Scale (HAMD scoregt; = 17 points, a total of 30 cases. including 14 males and 16 females, aged 65 to 82 years, mean 73.6 years, onset age of 58 to 81 years, average 68.4 years of age, duration of 0.36 to 18 years with an average of 5.8 years .70 % of patients suffering from other physical diseases, hypertension in 8 cases, 2 cases of cerebral infarction, vascular dementia in 5 cases, 2 cases of coronary heart disease, diabetes in 3 cases, 1 case of cerebral hemorrhage, is the appropriate drug treatment. 1.2 The method to disable the original anti-anxiety drugs 1 week, start